Ancell Corporation – High-Quality Immunology Research Reagents - Distributed in the UK & Ireland by Caltag Medsystems

Ancell Corporation

Ancell Corporation manufactures and supplies monoclonal antibodies, recombinant fusion proteins, isotype controls and second-step reagents for immunology research. Because of the high performance characteristics and quality, and their expertise, Ancell’s antibodies and proteins are widely recognised reagents and are used and cited in many scientific publications.

Ancell offers an extensive range of human CD antibodies. Their products are purified and conjugated under optimised conditions and rigorously tested in cell lines and human samples by their experienced in-house development team. Most of the antibodies are developed and variously labelled to perform in multiple applications, including flow cytometry, blocking, immunohistochemistry and immunofluorescence. Several antibodies have functional applications (antagonistic antibodies). Ancell also offers a broad range of labelled and unlabelled biologically active recombinant fusion proteins that are complementary to their CD marker antibody panel.

CD markers are an extremely diverse series of leukocyte surface proteins, used as cell markers, and found in various immune cell populations, such as B cells, thymocytes and T cells. CD proteins serve as receptors and ligands, and regulate cell signalling, cell adhesion and adaptive immunity. CD molecules are utilised in cell sorting techniques and cell populations are usually defined as either positive or negative, to indicate whether or not the cell fraction expresses a particular CD molecule. High-quality monoclonal antibodies against the CD markers allow researchers to easily examine cellular signalling events in complex cell populations and are commonly used for immunology, cancer and stem cell biology research.

The collaboration between Ancell Corporation and AdipoGen Life Sciences allows us to bring the Ancell product range to our UK & Ireland customers.

More AdipoGen Brands

Blog posts

Cytokine Storm and Severity of COVID-19

The most critically ill COVID-19 patients undergo a cytokine storm leading to poor prognosis & need urgent anti-inflammatory treatment/hospitalisation.

More

Documents

  Category Title  
Ancell Product Flyer 2022Immunology DocumentsAncell Product Flyer 2022  View
Ancell Corporation manufactures and supplies monoclonal antibodies, recombinant fusion proteins, isotype controls and second step reagents for immunology research.  
Show more...